Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Accuracy of Down's syndrome risks produced in a prenatal screening program.

K Spencer1

  • 1Clinical Biochemistry Department, Harold Wood Hospital, Romford, UK.

Annals of Clinical Biochemistry
|June 17, 1999
PubMed
Summary

Second-trimester Down

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical Oncologist and NHS Commissioner Perspectives on Reirradiation for Recurrent Cancer.

Clinical oncology (Royal College of Radiologists (Great Britain))·2026
Same author

Patient Perspectives on Reirradiation for Recurrent Cancer, to Inform Future Clinical Trial Design.

Clinical oncology (Royal College of Radiologists (Great Britain))·2026
Same author

Radiotherapy for Oesophageal Cancer in the United Kingdom: Patterns of Practice and Quality Indicators.

Clinical oncology (Royal College of Radiologists (Great Britain))·2025
Same author

Developing an evidence base to inform retirement home policy development using an equity and diversity lens: a mixed methods study protocol.

BMC geriatrics·2025
Same author

Tackle Height and Tackle Success-An Analysis of 52,204 Tackle Events.

European journal of sport science·2025
Same author

Perspectives on Academic Training in Clinical Oncology in the United Kingdom: A National Cross-Sectional Analysis.

Clinical oncology (Royal College of Radiologists (Great Britain))·2024

Area of Science:

  • Prenatal diagnostics
  • Maternal serum screening
  • Statistical risk assessment

Background:

  • Second-trimester Down's syndrome screening using maternal serum markers is standard antenatal care.
  • Risk calculation relies on statistical models, often using specialized, closed-system software.
  • Lack of transparency in software parameters leads to uncertainty.

Purpose of the Study:

  • To address the confusion and uncertainty surrounding Down's syndrome risk calculation methods.
  • To highlight the need for transparency and validation of screening software parameters.
  • To improve the reliability of risk estimates in prenatal screening programs.

Main Methods:

  • Review of current Down's syndrome screening methodologies.
  • Analysis of statistical models based on Gaussian distribution functions for maternal serum markers.
  • Discussion of issues related to proprietary screening software and population parameters.

Main Results:

  • Many screening centers are unaware of the specific risk calculation methods and population parameters used in their software.
  • Inappropriate population parameters can compromise the accuracy of risk estimates.
  • The "closed system" nature of software prevents user verification and adjustment.

Conclusions:

  • Uncertainty exists regarding the reliability of Down's syndrome risk estimates due to opaque screening software.
  • There is a critical need for greater transparency and validation of the statistical models and parameters used in prenatal screening.
  • Ensuring appropriate population parameters is essential for accurate Down's syndrome risk assessment.

Related Experiment Videos